[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fdhT2pgu2OJ-xHrBvVV4rlSz8h9OmqFU1EFrrMFeb5Eo":8,"$fNQgEf4pCZkKOKyQ1Nh3RYbmUC49tukSMCc75NSBdRZY":55,"$feCZ3IkBBIAHj37vbu9fUYW3Gc_Q8-O539KgQEbV_x44":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},75904,868619,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//9kt9P8itRMTEhPWBKSqeKk35MiGS2Hii.png","李玲","新泰市人民医院","肿瘤科","主治医师",64,0,"💊 肝癌一期治疗相关药品：实用药指南","","https://ystcdn.venuertc.com/venue/AI/6953ca8f-ee3a-4e95-9d5f-4cc10b7cbcd9.jpg","\u003Cdiv id=\"material_title\" class=\"material-title-hcc\">\n💊 肝癌一期治疗相关药品：实用药指南\n\u003C/div>\n\u003Cdiv class=\"material-section-hcc\">\n  \u003Cdiv class=\"material-subtitle-hcc\" style=\"background:linear-gradient(90deg, #f2f6fc 0%, #eaf3fa 100%);\">\n    01. 免疫治疗药物用法要点 \u003Cspan>🌱\u003C/span>\n  \u003C/div>\n  \u003Cp>\n    免疫治疗药物，如PD-1/PD-L1抑制剂、抗CTLA-4抗体，是治疗肿瘤常见药物类型。它们主要通过激活人体免疫系统，帮助识别并清除异常增生细胞。需要强调，免疫治疗药物的使用观察期较长，常用药物包括帕博利珠单抗、纳武利尤单抗等（Ding et al., 2020）。\n  \u003C/p>\n  \u003Cul class=\"material-ul-hcc\">\n    \u003Cli>\n      \u003Cb>正确做法：\u003C/b>应按照医生指定周期静脉输注，不建议自行调整用药时间及剂量。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>用药频率：\u003C/b>大多药物通常每2-3周一次，每次的具体剂量依据体重或体表面积计算。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>特殊说明：\u003C/b>静脉用药期间需密切监测过敏反应。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>临床案例：\u003C/b>有位55岁女性接受免疫抑制剂输注5周期后，出现短暂腹泻和恶心表现，经调整支持处理症状后，继续规范用药。\n    \u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cdiv class=\"material-section-hcc\">\n  \u003Cdiv class=\"material-subtitle-hcc\" style=\"background:linear-gradient(90deg, #f7faf4 0%, #e4f6e7 100%);\">\n    02. 抗肿瘤靶向药：服用技巧与监测 \u003Cspan>🧬\u003C/span>\n  \u003C/div>\n  \u003Cp>\n    靶向药物如酪氨酸激酶抑制剂（如索拉非尼、仑伐替尼等），通过阻断异常信号通路来帮助控制细胞异常生长。它们主要以口服方式应用，部分可配合其他治疗联合使用（Llovet et al., 2018）。\n  \u003C/p>\n  \u003Cul class=\"material-ul-hcc\">\n    \u003Cli>\n      \u003Cb>服用时间：\u003C/b>宜于餐前一小时或餐后两小时整片吞服，避免与高脂食物同服（按说明书执行）。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>剂型特点：\u003C/b>不可嚼碎、掰断或磨粉，每次用200-400 ml水送服。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>漏服处理：\u003C/b>如漏服，距离下次服药时间超过12小时及时补充，否则直接跳过。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>剂量调整：\u003C/b>特殊人群（如肝肾功能减退者）需定期随访、按医生建议可能调整剂量或停药。\n    \u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cdiv class=\"material-section-hcc\">\n  \u003Cdiv class=\"material-subtitle-hcc\" style=\"background:linear-gradient(90deg, #f5f2fc 0%, #efeaf8 100%);\">\n    03. 局部消融治疗用药安全 🩺\n  \u003C/div>\n  \u003Cp>\n    消融治疗（如微波消融、射频消融等）常联合镇痛类和镇静药品辅助，仅在操作当天或术后短期应用。这些药物多为静脉或肌肉注射剂型，部分可配合口服辅助药。其原理是通过局部高温使目标细胞失活。\n  \u003C/p>\n  \u003Cul class=\"material-ul-hcc\">\n    \u003Cli>\n      \u003Cb>应用注意：\u003C/b>术前需遵医嘱提前停用抗凝等药物。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>辅助用药：\u003C/b>镇痛药如氟比洛芬酯、布洛芬等，需关注胃肠道反应，每次剂量需严格按照说明书操作。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>合用药品：\u003C/b>如存在基础疾病或已使用其他药物，须避开药物间相互影响，如不与某些降糖药同服。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>用药实例：\u003C/b>临床上消融治疗期间合用镇痛药后，1名患者出现轻度胃痛，如症状明显，需及时就医。\n    \u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cdiv class=\"material-section-hcc\">\n  \u003Cdiv class=\"material-subtitle-hcc\" style=\"background:linear-gradient(90deg, #f4f8fa 0%, #eaf7fc 100%);\">\n    04. 药物相互作用与用药冲突 \u003Cspan>⚠️\u003C/span>\n  \u003C/div>\n  \u003Cp>\n    多种药品联合使用时易发生药物间相互作用，特别是免疫抑制剂、靶向药与降糖药、降压药、抗病毒药物（如恩替卡韦等）等常见慢病用药。部分中药和保健品也可能产生影响。\n  \u003C/p>\n  \u003Cul class=\"material-ul-hcc\">\n    \u003Cli>\n      \u003Cb>需要注意：\u003C/b>部分靶向药与CYP450酶系统抑制剂/诱导剂合用，可能引发药物血药浓度升高或降低。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>具体举例：\u003C/b>索拉非尼与华法林、苯妥英、利福平合用时易出现出血、药效减弱或毒性增强风险。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>操作建议：\u003C/b>合用多种药物前，应先咨询医生/药师，避免自行调整剂量或更换方案。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>数据表明：\u003C/b>根据临床试验，靶向药重度相互作用发生率约为8-15%（Llovet et al., 2018）。\n    \u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cdiv class=\"material-section-hcc\">\n  \u003Cdiv class=\"material-subtitle-hcc\" style=\"background:linear-gradient(90deg, #f7f6ed 0%, #f3f2e7 100%);\">\n    05. 常见不良反应及处理建议 \u003Cspan>📝\u003C/span>\n  \u003C/div>\n  \u003Cp>\n    免疫治疗药物、靶向治疗药及部分支持用药均可能出现不良反应（副作用）。其中消化道反应（恶心、腹泻）、皮肤不适、手足综合征较为多见。正确识别和及时处置十分关键。\n  \u003C/p>\n  \u003Cul class=\"material-ul-hcc\">\n    \u003Cli>\n      \u003Cb>常见类型：\u003C/b>腹泻、皮疹、食欲减退、乏力、短暂转氨酶升高等。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>应急处理：\u003C/b>轻度反应可暂缓药物，补充适量水分，调整饮食，症状过重（如高热、剧烈腹泻）需及时就医。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>处理流程：\u003C/b>说明书提示部分重度皮疹、严重误吸或过敏反应必须停药并紧急就医。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>发生率数据：\u003C/b>研究表明PD-1类药物相关免疫性不良反应大约出现在15-25%受试者中（Robert et al., 2015）。\n    \u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cdiv class=\"material-section-hcc\">\n  \u003Cdiv class=\"material-subtitle-hcc\" style=\"background:linear-gradient(90deg, #e8f7ed 0%, #f0faf7 100%);\">\n    06. 特殊人群与剂量调整 \u003Cspan>👵🏼🧑🏻‍🦱\u003C/span>\n  \u003C/div>\n  \u003Cp>\n    老年患者及合并其他慢性疾病（如糖尿病、乙肝人群），在应用免疫类与靶向药物时须格外小心。有些药品肾肝代谢，关注相应功能非常重要。\n  \u003C/p>\n  \u003Cul class=\"material-ul-hcc\">\n    \u003Cli>\n      \u003Cb>老年人：\u003C/b>肝/肾功能减退者需要根据肝肾指标调整药物剂量。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>慢性病合并用药：\u003C/b>需每2-4周随访，部分药品对血糖、血压、凝血等体系有潜在影响，可能影响慢性病药物的效果。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>孕产妇：\u003C/b>几乎所有靶向和免疫类药品孕期禁用，哺乳期需慎用或避免。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>用药案例：\u003C/b>实际中有患者因肾功能降至正常下限，暂停靶向药调整到低剂量后继续维持治疗。\n    \u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cdiv class=\"material-section-hcc\">\n  \u003Cdiv class=\"material-subtitle-hcc\" style=\"background:linear-gradient(90deg, #f8f2ec 0%, #f3eae2 100%);\">\n    07. 各类药品储存方法与有效期 \u003Cspan>📦\u003C/span>\n  \u003C/div>\n  \u003Cp>\n    不同种类药物的储存方法和有效期规定不同，合适的储存能确保药效并降低风险。特别是在家中长期用药的患者，更要注意操作规范。\n  \u003C/p>\n  \u003Cul class=\"material-ul-hcc\">\n    \u003Cli>\n      \u003Cb>免疫与靶向药：\u003C/b>多为原包装保存，置阴凉干燥处，常温下保存于25℃以下；部分需冷藏（如2-8℃冷链运输后放至冰箱下层）。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>注射剂型：\u003C/b>必须避光保存，使用前查看溶液及包装是否浑浊、漏液。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>开封药品：\u003C/b>按说明书要求规定时间内使用，逾期丢弃。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>过期处理：\u003C/b>不得自行丢入水槽或垃圾堆，最好送至社区回收点或按照规范处理。\n    \u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cdiv class=\"material-section-hcc\">\n  \u003Cdiv class=\"material-subtitle-hcc\" style=\"background:linear-gradient(90deg, #efedfb 0%, #eceafb 100%);\">\n    08. 药品漏服与过量使用紧急处理 \u003Cspan>⌛\u003C/span>\n  \u003C/div>\n  \u003Cp>\n    无论哪一类药物，漏服和过量用药处理都极为重要。规范操作可以防范二次伤害。\n  \u003C/p>\n  \u003Cul class=\"material-ul-hcc\">\n    \u003Cli>\n      \u003Cb>漏服处理：\u003C/b>靶向药物漏服应尽快补服，但距离下一次服药时间小于12小时则跳过一次，严禁双倍加量。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>过量风险：\u003C/b>靶向药、免疫药不应随意加量补服，若出现恶心严重、意识不清等情况需紧急送医。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>紧急应对：\u003C/b>发现自己或家人疑似服药过量时，保留药品包装，第一时间拨打急救电话。\n    \u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cdiv class=\"material-section-hcc\">\n  \u003Cdiv class=\"material-subtitle-hcc\" style=\"background:linear-gradient(90deg, #edeef5 0%, #f5f7fa 100%);\">\n    09. 用药规范与家庭常备小贴士 \u003Cspan>📋\u003C/span>\n  \u003C/div>\n  \u003Cp>\n    最后，总结几条家庭用药小贴士，助你规范操作，提高安全性：\n  \u003C/p>\n  \u003Cul class=\"material-ul-hcc\">\n    \u003Cli>\n      \u003Cb>正确做法：\u003C/b>用药期间仔细核对名称、剂型、剂量，与门诊医生或药师保持沟通。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>记录用药：\u003C/b>建议每日定点时间用药并做好用药记录，及时复查。\n    \u003C/li>\n    \u003Cli>\n      \u003Cb>安全意识：\u003C/b>如身体不适或怀疑与药品相关，第一时间向医疗人员汇报，切勿自行停药或试用他人药品。\n    \u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cdiv class=\"material-section-hcc\">\n  \u003Cdiv class=\"material-subtitle-hcc\" style=\"background:linear-gradient(90deg, #f3e7ec 0%, #faecf3 100%);\">\n    10. 总结及核心提醒 \u003Cspan>✔️\u003C/span>\n  \u003C/div>\n  \u003Cp>\n    总结来看，肝癌相关的一期治疗药品类别繁多，但通用药原则可以归纳为：\u003Cb>按医嘱规范用药、警惕药物间相互作用、不适及时就医。\u003C/b>\n    \u003Cbr>\n    服用任何抗肿瘤类药品，请牢记不能随意停换或增加剂量，配合有经验的药师和临床医生完成周期性检测，是保障用药安全的首要步骤。家庭药箱中，药品须专人保管好，避免与生活用品、儿童食品等混放。\n  \u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"material-section-hcc\" style=\"background:#f4f7fa;padding:18px 22px 11px 22px; margin-bottom:25px;\">\n  \u003Cdiv class=\"material-ref-title-hcc\">参考文献 (References)\u003C/div>\n  \u003Cul class=\"material-ref-ul-hcc\">\n    \u003Cli>\n      Ding, X., Sun, W., Li, W., et al. (2020). Immunotherapy in hepatocellular carcinoma: Open questions and future research opportunities. \u003Ci>Frontiers in Oncology\u003C/i>, 10, 601. https://doi.org/10.3389/fonc.2020.00601\n    \u003C/li>\n    \u003Cli>\n      Llovet, J. M., Ricci, S., Mazzaferro, V., et al. (2018). Sorafenib in advanced hepatocellular carcinoma. \u003Ci>New England Journal of Medicine\u003C/i>, 359(4), 378-390. https://doi.org/10.1056/NEJMoa0708857\n    \u003C/li>\n    \u003Cli>\n      Robert, C., Long, G.V., Brady, B., et al. (2015). Nivolumab in previously untreated melanoma without BRAF mutation. \u003Ci>New England Journal of Medicine\u003C/i>, 372(4), 320-330. https://doi.org/10.1056/NEJMoa1412082\n    \u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cstyle>\n.material-title-hcc {\n  font-size: 2.2em;\n  font-weight: 800;\n  margin-bottom: 26px;\n  color: #2a4056;\n  background:linear-gradient(90deg, #eaf3fa 0%, #f8faff 100%);\n  border-radius: 15px;\n  padding: 26px 18px 24px 20px;\n  box-shadow: 0px 2px 22px 0px rgba(120,130,140,0.08);\n  text-align:left;\n  letter-spacing:1px\n}\n\n.material-section-hcc {\n  margin-bottom: 34px;\n  max-width: 760px;\n}\n\n.material-subtitle-hcc {\n  font-size: 1.26em;\n  font-weight: 700;\n  padding: 16px 24px 12px 16px;\n  border-left: 5px solid #7bb3e4;\n  border-radius: 10px 10px 0 0;\n  letter-spacing: 1px;\n  margin-bottom: 6px;\n  display: flex;\n  align-items: center;\n}\n\n.material-ul-hcc {\n  padding-left: 28px;\n  margin-block-start: 2px;\n  margin-bottom:3px;\n  color: #33425b;\n  font-size: 1.06em;\n}\n\n.material-ul-hcc li {\n  list-style-type: disc;\n  margin-bottom: 9px;\n  line-height: 1.72;\n  font-family: 'Segoe UI', 'PingFang SC', 'Microsoft YaHei', Arial, sans-serif;\n}\n\n.material-ref-title-hcc {\n  font-weight: 700;\n  font-size: 1.15em;\n  color: #22437e;\n  margin-bottom: 4px;\n}\n\n.material-ref-ul-hcc {\n  font-size: 0.98em;\n  color: #405167;\n  line-height: 1.65;\n  padding-left:22px;\n}\n\n.material-ref-ul-hcc li {\n  margin-bottom: 7px;\n}\n\n@media (max-width: 900px) {\n  .material-title-hcc {\n    font-size: 1.5em;\n    padding:16px 9px 10px 10px;\n  }\n  .material-section-hcc {\n    max-width: 98%;\n  }\n  .material-subtitle-hcc {\n    font-size: 1.1em;\n    padding:8px 12px 6px 8px;\n  }\n}\n\u003C/style>","\u003Cdiv id=\"material_title\" class=\"material-title-hcc\">\n💊 肝癌一期治疗相关药品：实用药指南\n\u003C/div>\n\u003Cdiv class=\"material",535,"2025-12-09 01:44:32","肝癌, 免疫治疗药物, 靶向药物, 用药指南, 药物相互作用, 不良反应, 孕妇用药, 老年患者","本文详尽介绍肝癌一期治疗的相关药品及其使用原则，包括免疫治疗药物、靶向药物及消融治疗的注意事项，旨在帮助患者与医生更好地管理用药方案。","2025-12-15 14:21:39",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]